Evidence map›Paper›PMID 42299298›Full record

ArticleGland surgery2026

Gynecologic tumors in Thai women with breast cancer: a cross-sectional surveillance and ten-year cohort study.

Preeyaporn Jirakittidul, Manee Rattanachaiyanont, Suchada Indhavivadhana, Chongdee Dangrat, Patsama Vichinsartvichai, Visnu Lohsiriwat

Abstract read
In one paragraph

Article in Gland surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Preeyaporn JirakittidulGynecologic Endocrinology Unit, Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.ORCID https://orcid.org/0000-0003-0221-9789
Manee RattanachaiyanontGynecologic Endocrinology Unit, Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.ORCID https://orcid.org/0000-0002-4533-9249
Suchada IndhavivadhanaGynecologic Endocrinology Unit, Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.ORCID https://orcid.org/0000-0002-6658-100X
Chongdee DangratGynecologic Endocrinology Unit, Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.ORCID https://orcid.org/0000-0002-1218-3532
Patsama VichinsartvichaiGynecologic Endocrinology Unit, Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.ORCID https://orcid.org/0000-0002-4501-9384
Visnu LohsiriwatDivision of Head-Neck and Breast Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.ORCID https://orcid.org/0000-0002-6815-3551

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Breast cancer and gynecologic tumors share common hormonal and genetic risk factors. Previous studies mainly focused on the risk of endometrial pathology in women receiving tamoxifen, while the data on the overall prevalence of concurrent and subsequent gynecologic tumors in patients with breast cancer, especially in Asian populations, remain limited. Clarifying this association is important to survey the prevalence of concurrent gynecologic tumors and the incidence of Methods: An initial cross-sectional study was conducted at the Faculty of Medicine Siriraj Hospital, Mahidol University. Participants were women scheduled for breast cancer surgery between September 2007 and January 2009. They were investigated for gynecologic tumors using clinical examination, cervical cytology testing, and pelvic ultrasonography; additional procedures were as indicated. In 2019, data from this cohort were reviewed for the Results: Concurrent gynecologic tumors were identified in 114 of 281 women (40.6%) with newly diagnosed breast cancer; most tumors were benign, including leiomyoma, adenomyosis, endometrial polyp, and ovarian tumor. Synchronous genital cancers were found in two cases, giving a prevalence of 0.7% [95% confidence interval (CI): 0.3-1.7]. During the 10-year follow-up period, Conclusions: Gynecologic tumors are prevalent in Thai women with breast cancer. The second primary genital cancers, both synchronous and metachronous, are not uncommon. Therefore, surveillance for the concurrent gynecologic tumors and further follow-up for the

Indexed as

breast cancerendometrial cancerGynecologic tumorsovarian cancersynchronous cancer

Identifiers

PMID42299298
PMCPMC13264784

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.